DaVita's Profit Growth Prospects Boosted by Share Repurchases
After selling DaVita Medical Group in 2019, DaVita focuses on providing services to end-stage renal disease, or ESRD, patients primarily in the United States, although its international footprint is expanding organically and through acquisitions. Over several decades, DaVita has built one of the largest networks of dialysis clinics in the US, and although covid-related mortality and labor pressures cut into its profits in recent years, we see brighter days ahead for the firm, despite long-term potential challenges emerging related to the expansion of obesity drugs.
United States